Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.

Nakayama Y, Inoue H, Hamada Y, Takeshita M, Iwasaki H, Maeshiro K, Iwanaga S, Tani H, Ryu S, Yasunami Y, Ikeda S.

Am J Surg Pathol. 2005 May;29(5):607-16.

PMID:
15832084
2.

Pyloric gland adenoma of the main pancreatic duct.

Bakotic BW, Robinson MJ, Sturm PD, Hruban RH, Offerhaus GJ, Albores-Saavedra J.

Am J Surg Pathol. 1999 Feb;23(2):227-31.

PMID:
9989851
3.
5.

The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas.

Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G.

Am J Surg Pathol. 2002 Apr;26(4):466-71.

PMID:
11914624
6.

Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms.

Shibahara H, Tamada S, Goto M, Oda K, Nagino M, Nagasaka T, Batra SK, Hollingsworth MA, Imai K, Nimura Y, Yonezawa S.

Am J Surg Pathol. 2004 Mar;28(3):327-38.

PMID:
15104295
7.
8.

Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.

Nagata S, Ajioka Y, Nishikura K, Watanabe G, Inoue T, Yamaguchi K, Watanabe H, Tanaka M, Tsuneyoshi M.

Oncol Rep. 2007 Apr;17(4):721-9.

PMID:
17342306
9.

Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant.

Adsay V, Logani S, Sarkar F, Crissman J, Vaitkevicius V.

Am J Surg Pathol. 2000 Apr;24(4):493-504.

PMID:
10757396
10.

p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.

Kawahira H, Kobayashi S, Kaneko K, Asano T, Ochiai T.

Hepatogastroenterology. 2000 Jul-Aug;47(34):973-7.

PMID:
11020860
12.

Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.

Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.

Oncol Rep. 2003 Jan-Feb;10(1):21-5.

PMID:
12469138
13.

Intraductal tubular carcinoma, intestinal type, of the pancreas.

Terada T.

Pathol Int. 2009 Jan;59(1):53-8. doi: 10.1111/j.1440-1827.2008.02325.x.

PMID:
19121093
14.

Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.

Adsay V, Jang KT, Roa JC, Dursun N, Ohike N, Bagci P, Basturk O, Bandyopadhyay S, Cheng JD, Sarmiento JM, Escalona OT, Goodman M, Kong SY, Terry P.

Am J Surg Pathol. 2012 Sep;36(9):1279-301.

PMID:
22895264
15.

Intraductal tubular adenoma, pyloric type, of the pancreas: additional observations on a new type of pancreatic neoplasm.

Albores-Saavedra J, Sheahan K, O'Riain C, Shukla D.

Am J Surg Pathol. 2004 Feb;28(2):233-8.

PMID:
15043313
16.
17.
18.

MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).

Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.

Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403.

PMID:
15816444
19.

Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.

Basturk O, Zamboni G, Klimstra DS, Capelli P, Andea A, Kamel NS, Adsay NV.

Am J Surg Pathol. 2007 Mar;31(3):363-70.

PMID:
17325477
20.

Intraductal tubular neoplasms of the bile ducts.

Katabi N, Torres J, Klimstra DS.

Am J Surg Pathol. 2012 Nov;36(11):1647-55. doi: 10.1097/PAS.0b013e3182684d4f.

PMID:
23073323

Supplemental Content

Support Center